Ignite Creation Date:
2025-12-25 @ 4:42 AM
Ignite Modification Date:
2026-03-04 @ 10:24 PM
Study NCT ID:
NCT04379518
Status:
SUSPENDED
Last Update Posted:
2023-03-06
First Post:
2020-05-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients
Sponsor:
Roswell Park Cancer Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
I 659920
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |